Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
Author(s) | Date |
Article Title![]() |
Journal |
---|---|---|---|
Bethany Pitcher, Leila Khoja, Robert J. Hamilton, Kald Abdallah, Melania Pintilie, Anthony M. Joshua |
February 2017 | Assessment of a Prognostic Model, PSA Metrics and Toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere. | PLOS ONE |
Wei-Xiang Qi, Yi Xiang, Shengguang Zhao & Jiayi Chen |
April 2021 | Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab | Cancer Immunology, Immunotherapy |
Guru Sonpavdea, Gregory R.Pond, Arnoud J.Templeton, Abderrahim Fandi, Bertrand Tombale, Mark Rosenthal, Andrew J.Armstrong, Daniel P.Petrylakh |
June 2016 | Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel | European Urology |
Zahra Azizi, Chaoyi Zheng, Lucy Mosquera, Louise Pilote, Khaled El Emam, GOING-FWD Collaborators Correspondence to Dr Khaled El Emam; kelemam@ehealthinformation.ca |
March 2021 | Can synthetic data be a proxy for real clinical trial data? A validation study | BMJ Open |
Deborah Plana, Geoffrey Fell, Brian M. Alexander, Adam C. Palmer & Peter K. Sorger |
February 2022 | Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications |
Jeffrey West, Yongqian Ma, Paul K. Newton |
October 2018 | Capitalizing on Competition: An Evolutionary Model of Competitive Release in Metastatic Castration Resistant Prostate Cancer Treatment | Journal of Theoretical Biology |
Shiyu Jiang, Liling Huang, Hongnan Zhen, Peijie Jin, Jing Wang & Zhihuang Hu |
December 2021 | Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis | BMC Cancer |
Enrique Vazquez, Henri Gouraud, Florian Naudet, Cary P Gross, Harlan M Krumholz, Joseph S Ross, Joshua D Wallach |
August 2021 | Characteristics of available studies and dissemination of research using major clinical data sharing platforms | Clinical Trials |
Lixia Wu, Lina Zhu, Kequn Xu, Siyuan Zhou, Yang Zhou, Tiening Zhang, Junjie Hang, Benny Chung-Ying Zee |
January 2021 | Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data | Journal of Cancer |
Toby Wilkinson, Siddharth Sinha, Niels Peek and Nophar Geifman |
August 2019 | Clinical trial data reuse – overcoming complexities in trial design and data sharing | Trials |
Teemu D. Laajala, Justin Guinney, James C. Costello |
September 2017 | Community mining of open clinical trial data | Oncotarget |
Angela K. Green, Robert W. Corty, William A. Wood, Mathew Meeneghan, Katherine E. Reeder-Hayes, Ethan Basch, Matthew I Milowsky, Stacie B. Dusetzina |
May 2015 | Comparative Effectiveness of Mitoxantrone plus Prednisone versus Prednisone alone in Metastatic Castrate-resistant Prostate Cancer after Docetaxel Failure | The Oncologist |
Omar Abdel-Rahman |
March 2019 | Comparison of outcomes of radiotherapy-treated localized prostate cancer patients within a clinical trial setting versus real-life setting | Future Oncology |
Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Teilo H Schaller, Anthony A Amato, Allison Betof Warner, Priscilla K Brastianos, Tracey A Cho, Stacey L Clardy, Justine V Cohen, Jorg Dietrich, Michael Dougan, Christopher T Doughty, Divyanshu Dubey, Jeffrey M Gelfand, Jeffrey T Guptill, Douglas B Johnson, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Jenny Linnoila, Andrew L Mammen, Maria Martinez-Lage, Meghan J Mooradian, Jarushka Naidoo, Tomas G Neilan, David A Reardon, Krista M Rubin, Bianca D Santomasso, Ryan J Sullivan, Nancy Wang, Karin Woodman, Leyre Zubiri, William C Louv, Kerry L Reynolds |
July 2021 | Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors | Journal for ImmunoTherapy of Cancer |